Park Square Places Jamie Lewis as Chief Commercial Officer at Inflammatix
Park Square is pleased to announce the placement of Jamie Lewis as Chief Commercial Officer at Inflammatix. Inflammatix is a pioneering...
Park Square is pleased to announce the placement of Jamie Lewis as Chief Commercial Officer at Inflammatix. Inflammatix is a pioneering...
Park Square has placed Frederick Beddingfield III, M.D., Ph.D., as Chief Executive Officer at Rubedo Life Sciences.
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive...…
Park Square has placed Alexandra Joseph, Ph.D., as Chief Scientific Officer at Photys Therapeutics.
Photys Therapeutics, a pioneer in the development of phosphorylationinducing chimeric small molecule medicines (PHICS), announced the...…
Park Square is pleased to announce the placement of Julia Tran at Xaira Therapeutics, where she will lead the People and Culture...
Park Square has placed Bill Colston, Ph.D., as Chief Executive Officer at CS Genetics.
CS Genetics, a privately held genomics technology company, today announced the appointment of Bill Colston, PhD, as Chief Executive Officer.
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net